HSBC Downgrades Eli Lilly to Reduce, Lowers Price Target to $850

Benzinga Newsdesk www.benzinga.com Negative 88.3%

Neg 88.3% Neu 0% Pos 0%

HSBC analyst Rajesh Kumar downgrades Eli Lilly (NYSE:LLY) from Hold to Reduce and lowers the price target from $1070 to $850.